180 related articles for article (PubMed ID: 8281664)
1. Augmentation of the synthesis of plasminogen activator inhibitor type-1 by precursors of insulin. A potential risk factor for vascular disease.
Nordt TK; Schneider DJ; Sobel BE
Circulation; 1994 Jan; 89(1):321-30. PubMed ID: 8281664
[TBL] [Abstract][Full Text] [Related]
2. Attenuation by gemfibrozil of expression of plasminogen activator inhibitor type 1 induced by insulin and its precursors.
Nordt TK; Kornas K; Peter K; Fujii S; Sobel BE; Kübler W; Bode C
Circulation; 1997 Feb; 95(3):677-83. PubMed ID: 9024157
[TBL] [Abstract][Full Text] [Related]
3. Induction of plasminogen activator inhibitor type-1 (PAI-1) by proinsulin and insulin in vivo.
Nordt TK; Sawa H; Fujii S; Sobel BE
Circulation; 1995 Feb; 91(3):764-70. PubMed ID: 7828304
[TBL] [Abstract][Full Text] [Related]
4. Augmentation of synthesis of plasminogen activator inhibitor type-1 in arterial endothelial cells by glucose and its implications for local fibrinolysis.
Nordt TK; Klassen KJ; Schneider DJ; Sobel BE
Arterioscler Thromb; 1993 Dec; 13(12):1822-8. PubMed ID: 8241103
[TBL] [Abstract][Full Text] [Related]
5. Stimulation by proinsulin of expression of plasminogen activator inhibitor type-I in endothelial cells.
Schneider DJ; Nordt TK; Sobel BE
Diabetes; 1992 Jul; 41(7):890-5. PubMed ID: 1612205
[TBL] [Abstract][Full Text] [Related]
6. Stimulation in vivo of expression of intra-abdominal adipose tissue plasminogen activator inhibitor Type I by proinsulin.
Nordt TK; Bode C; Sobel BE
Diabetologia; 2001 Sep; 44(9):1121-4. PubMed ID: 11596666
[TBL] [Abstract][Full Text] [Related]
7. Augmentation of arterial endothelial cell expression of the plasminogen activator inhibitor type-1 (PAI-1) gene by proinsulin and insulin in vivo.
Nordt TK; Sawa H; Fujii S; Bode C; Sobel BE
J Mol Cell Cardiol; 1998 Aug; 30(8):1535-43. PubMed ID: 9737940
[TBL] [Abstract][Full Text] [Related]
8. Proinsulin-like molecules and plasminogen activator inhibitor type 1 (PAI-1) activity in diabetic and non-diabetic subjects with and without myocardial infarction.
Gray RP; Panahloo A; Mohamed-Ali V; Patterson DL; Yudkin JS
Atherosclerosis; 1997 Apr; 130(1-2):171-8. PubMed ID: 9126661
[TBL] [Abstract][Full Text] [Related]
9. Attenuated fibrinolysis and accelerated atherogenesis in type II diabetic patients.
Schneider DJ; Nordt TK; Sobel BE
Diabetes; 1993 Jan; 42(1):1-7. PubMed ID: 8420806
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of the synthesis of plasminogen activator inhibitor type 1 by niacin. A potential link between lipid lowering and fibrinolysis.
Brown SL; Sobel BE; Fujii S
Circulation; 1995 Aug; 92(4):767-72. PubMed ID: 7641354
[TBL] [Abstract][Full Text] [Related]
11. Constitutive biosynthesis of plasminogen activator inhibitor type-1 (PAI-1) by cultured human aortic endothelial cells independent of insulin.
Klassen KJ; Nordt TK; Schneider DJ; Sobel BE
Coron Artery Dis; 1993 Aug; 4(8):713-9. PubMed ID: 8261243
[TBL] [Abstract][Full Text] [Related]
12. Determinants of plasminogen activator inhibitor 1 activity in treated NIDDM and its relation to a polymorphism in the plasminogen activator inhibitor 1 gene.
Panahloo A; Mohamed-Ali V; Lane A; Green F; Humphries SE; Yudkin JS
Diabetes; 1995 Jan; 44(1):37-42. PubMed ID: 7813812
[TBL] [Abstract][Full Text] [Related]
13. Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with nondiabetic patients: a potential factor predisposing to thrombosis and its persistence.
Sobel BE; Woodcock-Mitchell J; Schneider DJ; Holt RE; Marutsuka K; Gold H
Circulation; 1998 Jun; 97(22):2213-21. PubMed ID: 9631870
[TBL] [Abstract][Full Text] [Related]
14. Synergistic augmentation of expression of plasminogen activator inhibitor type-1 induced by insulin, very-low-density lipoproteins, and fatty acids.
Schneider DJ; Sobel BE
Coron Artery Dis; 1996 Nov; 7(11):813-7. PubMed ID: 8993938
[TBL] [Abstract][Full Text] [Related]
15. Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS).
Festa A; D'Agostino R; Mykkänen L; Tracy RP; Zaccaro DJ; Hales CN; Haffner SM
Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):562-8. PubMed ID: 10073958
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator inhibitor (PAI-1) and non-insulin-dependent diabetes in Pima Indians, south Asians and Europeans. Populations at varying risk of NIDDM and coronary artery disease.
Nagi DK; Knowler WC; Hanson RL; Ali VM; Yudkin JS
Thromb Haemost; 1996 Jun; 75(6):921-7. PubMed ID: 8822587
[TBL] [Abstract][Full Text] [Related]
17. Insulin therapy in type 2 diabetic subjects suppresses plasminogen activator inhibitor (PAI-1) activity and proinsulin-like molecules independently of glycaemic control.
Jain SK; Nagi DK; Slavin BM; Lumb PJ; Yudkin JS
Diabet Med; 1993; 10(1):27-32. PubMed ID: 8435984
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activator inhibitor-1 synthesis in the human hepatoma cell line Hep G2. Metformin inhibits the stimulating effect of insulin.
Anfosso F; Chomiki N; Alessi MC; Vague P; Juhan-Vague I
J Clin Invest; 1993 May; 91(5):2185-93. PubMed ID: 8387542
[TBL] [Abstract][Full Text] [Related]
19. Dependence of augmentation of arterial endothelial cell expression of plasminogen activator inhibitor type 1 by insulin on soluble factors released from vascular smooth muscle cells.
Schneider DJ; Absher PM; Ricci MA
Circulation; 1997 Nov; 96(9):2868-76. PubMed ID: 9386151
[TBL] [Abstract][Full Text] [Related]
20. Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.
Kruszynska YT; Yu JG; Olefsky JM; Sobel BE
Diabetes; 2000 Apr; 49(4):633-9. PubMed ID: 10871202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
